TLRY - Tilray Brands, Inc.
IEX Last Trade
1.485
0.020 1.347%
Share volume: 272,558
Last Updated: Thu 26 Dec 2024 08:30:33 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$1.46
0.02
1.37%
Fundamental analysis
24%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
40%
Performance
5 Days
-1.40%
1 Month
3.68%
3 Months
-18.97%
6 Months
-16.57%
1 Year
-38.43%
2 Year
-49.46%
Key data
Stock price
$1.48
DAY RANGE
$1.38 - $1.47
52 WEEK RANGE
$1.22 - $2.97
52 WEEK CHANGE
-$41.49
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/03/2024
Company detail
CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: tilray.com
Employees: 1,700
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.
Recent news